As of 2026-07-01, the Intrinsic Value of Vor Biopharma Inc (VOR) is -81.48 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 18.41 USD, the upside of Vor Biopharma Inc is -542.59%.
Based on its market price of 18.41 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 542.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -81.48 - -81.48 | -81.48 | -542.59% |
| P/E | (307.99) - (371.55) | (334.07) | -1914.6% |
| DDM - Stable | (207.19) - (941.86) | (574.53) | -3220.7% |
| DDM - Multi | (2.63) - (8.96) | (4.03) | -121.9% |
| Market Cap (mil) | 997.64 |
| Beta | 8.85 |
| Outstanding shares (mil) | 54.19 |
| Enterprise Value (mil) | 827.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.53% |
| Cost of Debt | 5.00% |
| WACC | 5.60% |